News

Under the terms of the agreement, Artes Medical will receive exclusive distribution and marketing rights for Elevess in the US. Elevess is an injectable filler that reduces the

This positive recommendation follows a regularly scheduled meeting of the data safety monitoring board (DSMB) in June 2008, and is based upon an evaluation of clinical, magnetic resonance

The Phase III study will involve up to 750 patients with Type-1 Diabetes Mellitus centers in the US, Canada, Russia, and Eastern Europe. Dosing of patients is now

As part of this 10 year agreement (with two additional five year renewal terms), Luitpold will continue to contract manufacture these products for Fresenius Medical Care. The transaction

Loxonin tape is said to be the first loxoprofen sodium adhesive tape in Japan containing the same constituents as Loxonin pills and Loxonin powder which are the leading

The ongoing pregnancy rate, the primary endpoint of this non-inferiority trial, obtained in the 150mcg corifollitropin alfa treatment arm (38.9% per started cycle) was similar to that achieved

Angiotech will contribute to Angiotech Pharmaceutical Interventions (API) certain business assets and intellectual property, which include primarily business assets of Angiotech other than the intellectual property and royalty

The companies plan to design, develop and manufacture solutions, which include sensors and delivery products, to support targeted markets enabling the advancement of patient care. These products will

Patheon will provide formulation and analytical development services as well as clinical supplies for one of the CNS candidates in multiple dosage forms for SK Life Science’s advanced